To further study the role of NF-kB signaling in the proliferation of HN12 cells adherent to carcinoma matrix we treated adherent cells with 30 μM cisplatin in combination with NF-kB peptide inhibitors. The gene discussed is NFKB1; the disease is carcinoma.